Symbiotec Pharmalab IPO \u2013 Flattrade Kosh<\/title>\n <style>\n \/* ==========================================================================\n 1. DESIGN TOKENS & RESET\n ========================================================================== *\/\n :root {\n --brand-primary: #16a34a;\n --brand-primary-hover: #15803d;\n --brand-light: #f0fdf4;\n --brand-border: #bbf7d0;\n \n --neutral-900: #0f172a;\n --neutral-800: #1e293b;\n --neutral-700: #334155;\n --neutral-600: #475569;\n --neutral-500: #64748b;\n --neutral-200: #e2e8f0;\n --neutral-100: #f1f5f9;\n --neutral-50: #f8fafc;\n --surface: #ffffff;\n \n --radius-sm: 6px;\n --radius-md: 10px;\n --radius-lg: 16px;\n --radius-full: 9999px;\n \n --shadow-subtle: 0 1px 3px rgba(0, 0, 0, 0.04), 0 1px 2px rgba(0, 0, 0, 0.02);\n --shadow-card: 0 4px 12px -2px rgba(15, 23, 42, 0.06), 0 2px 6px -2px rgba(15, 23, 42, 0.04);\n --shadow-hover: 0 12px 24px -4px rgba(15, 23, 42, 0.10);\n \n --font-stack: -apple-system, BlinkMacSystemFont, \"Segoe UI\", Roboto, Inter, \"Helvetica Neue\", sans-serif;\n }\n\n *, *::before, *::after {\n box-sizing: border-box;\n margin: 0;\n padding: 0;\n }\n\n body {\n font-family: var(--font-stack);\n background-color: var(--neutral-50);\n color: var(--neutral-700);\n line-height: 1.75;\n -webkit-font-smoothing: antialiased;\n }\n\n \/* ==========================================================================\n 2. LAYOUT WRAPPER\n ========================================================================== *\/\n .cmr-article-wrapper {\n max-width: 760px;\n margin: 32px px 64px;\n background: var(--surface);\n border: 1px solid var(--neutral-200);\n border-radius: var(--radius-lg);\n padding: 40px 32px;\n box-shadow: var(--shadow-card);\n }\n\n \/* ==========================================================================\n 3. HEADER & META\n ========================================================================== *\/\n .meta-bar {\n display: flex;\n align-items: center;\n gap: 10px;\n margin-bottom: 18px;\n }\n\n .tag-badge {\n display: inline-flex;\n align-items: center;\n gap: 6px;\n background: var(--brand-light);\n color: var(--brand-primary);\n border: 1px solid var(--brand-border);\n border-radius: var(--radius-full);\n padding: 3px 12px;\n font-size: 11px;\n font-weight: 700;\n letter-spacing: 0.06em;\n text-transform: uppercase;\n }\n\n .tag-badge::before {\n content: \"\";\n width: 6px;\n height: 6px;\n background-color: var(--brand-primary);\n border-radius: 50%;\n }\n\n .meta-source {\n font-size: 13px;\n font-weight: 500;\n color: var(--neutral-500);\n }\n\n h1.post-title {\n font-size: 28px;\n font-weight: 800;\n color: var(--neutral-900);\n line-height: 1.25;\n letter-spacing: -0.02em;\n margin-bottom: 24px;\n }\n\n h2.section-heading {\n font-size: 19px;\n font-weight: 700;\n color: var(--neutral-900);\n margin: 36px 0 16px;\n letter-spacing: -0.01em;\n display: flex;\n align-items: center;\n gap: 8px;\n }\n\n .cmr-article-wrapper p {\n font-size: 15.5px;\n margin-bottom: 18px;\n color: var(--neutral-700);\n text-align: justify;\n }\n\n .cmr-article-wrapper strong {\n color: var(--neutral-900);\n font-weight: 600;\n }\n\n \/* ==========================================================================\n 4. IPO AT A GLANCE GRID\n ========================================================================== *\/\n .cmr-glance-title {\n font-size: 12px;\n font-weight: 700;\n color: var(--neutral-500);\n text-transform: uppercase;\n letter-spacing: 0.08em;\n margin: 28px 0 14px;\n display: flex;\n align-items: center;\n gap: 12px;\n }\n\n .cmr-glance-title::after {\n content: '';\n flex: 1;\n height: 1px;\n background: var(--neutral-200);\n }\n\n .cmr-glance-grid {\n display: grid;\n grid-template-columns: repeat(3, 1fr);\n gap: 12px;\n margin-bottom: 16px;\n }\n\n .cmr-glance-item {\n background: var(--neutral-50);\n border: 1px solid var(--neutral-200);\n border-radius: var(--radius-md);\n padding: 16px;\n transition: all 0.2s ease-in-out;\n }\n\n .cmr-glance-item:hover {\n background: var(--surface);\n border-color: #cbd5e1;\n transform: translateY(-2px);\n box-shadow: var(--shadow-subtle);\n }\n\n .cmr-glance-item.cmr-highlight {\n background: linear-gradient(145deg, #ffffff, var(--brand-light));\n border-color: var(--brand-border);\n }\n\n .cmr-glance-item.cmr-highlight .cmr-g-value {\n color: var(--brand-primary);\n }\n\n .cmr-g-label {\n font-size: 11px;\n color: var(--neutral-500);\n text-transform: uppercase;\n font-weight: 600;\n letter-spacing: 0.04em;\n margin-bottom: 4px;\n }\n\n .cmr-g-value {\n font-size: 17px;\n font-weight: 800;\n color: var(--neutral-900);\n line-height: 1.25;\n }\n\n .cmr-g-sub {\n font-size: 12px;\n color: var(--neutral-500);\n margin-top: 4px;\n }\n\n .glance-badge {\n background: var(--neutral-100);\n border: 1px solid var(--neutral-200);\n border-radius: var(--radius-sm);\n padding: 10px 14px;\n font-size: 13px;\n color: var(--neutral-600);\n margin-bottom: 28px;\n font-weight: 500;\n text-align: center;\n }\n\n \/* ==========================================================================\n 5. FEATURE LISTS\n ========================================================================== *\/\n .cmr-feature-list {\n list-style: none;\n padding: 0;\n margin: 20px 0;\n display: flex;\n flex-direction: column;\n gap: 12px;\n }\n\n .cmr-feature-list li {\n position: relative;\n padding-left: 28px;\n font-size: 15px;\n color: var(--neutral-700);\n }\n\n .cmr-feature-list li::before {\n content: \"\u2713\";\n position: absolute;\n left: 0;\n top: 1px;\n width: 18px;\n height: 18px;\n background: var(--brand-light);\n color: var(--brand-primary);\n border: 1px solid var(--brand-border);\n border-radius: 50%;\n display: flex;\n align-items: center;\n justify-content: center;\n font-size: 11px;\n font-weight: 800;\n }\n\n \/* ==========================================================================\n 6. TABLES (FINANCIAL & RESERVATION)\n ========================================================================== *\/\n .table-container {\n width: 100%;\n overflow-x: auto;\n -webkit-overflow-scrolling: touch;\n margin: 18px 0;\n border: 1px solid var(--neutral-200);\n border-radius: var(--radius-md);\n background: var(--surface);\n }\n\n .fin-table, .res-table {\n width: 100%;\n border-collapse: collapse;\n font-size: 14.5px;\n text-align: left;\n }\n\n .fin-table th, .fin-table td,\n .res-table th, .res-table td {\n padding: 12px 18px;\n border-bottom: 1px solid var(--neutral-200);\n }\n\n .fin-table thead tr, .res-table thead tr {\n background: var(--neutral-100);\n }\n\n .fin-table th {\n font-weight: 700;\n color: var(--neutral-800);\n text-align: right;\n }\n\n .fin-table th:first-child, .res-table th {\n text-align: left;\n }\n\n .fin-table td {\n color: var(--neutral-700);\n text-align: right;\n font-variant-numeric: tabular-nums;\n }\n\n .res-table td {\n color: var(--neutral-700);\n text-align: left;\n }\n\n .fin-table td:first-child, .res-table td:first-child {\n text-align: left;\n font-weight: 600;\n color: var(--neutral-900);\n }\n\n .fin-table tbody tr:hover, .res-table tbody tr:hover {\n background-color: var(--neutral-50);\n }\n\n .fin-table tbody tr:last-child td, .res-table tbody tr:last-child td {\n border-bottom: none;\n }\n\n .fin-note {\n font-size: 12px;\n color: var(--neutral-500);\n margin-top: 6px;\n margin-bottom: 24px;\n }\n\n \/* ==========================================================================\n 7. KPI STATS CARDS\n ========================================================================== *\/\n .kpi-grid {\n display: grid;\n grid-template-columns: repeat(3, 1fr);\n gap: 12px;\n margin: 20px 0 28px;\n }\n\n .kpi-card {\n background: var(--neutral-50);\n border: 1px solid var(--neutral-200);\n border-radius: var(--radius-md);\n padding: 16px 12px;\n text-align: center;\n transition: all 0.2s ease;\n }\n\n .kpi-card:hover {\n background: var(--surface);\n border-color: var(--brand-border);\n transform: translateY(-2px);\n box-shadow: var(--shadow-subtle);\n }\n\n .kpi-card .kpi-value {\n font-size: 20px;\n font-weight: 800;\n color: var(--brand-primary);\n line-height: 1.2;\n }\n\n .kpi-card .kpi-label {\n font-size: 11px;\n color: var(--neutral-500);\n text-transform: uppercase;\n letter-spacing: 0.05em;\n margin-top: 4px;\n font-weight: 600;\n }\n\n \/* ==========================================================================\n 8. OBJECTS OF THE ISSUE LIST\n ========================================================================== *\/\n .objects-list {\n list-style: none;\n padding: 0;\n margin: 20px 0;\n display: flex;\n flex-direction: column;\n gap: 10px;\n }\n\n .objects-list li {\n display: flex;\n justify-content: space-between;\n align-items: center;\n padding: 14px 18px;\n border-radius: var(--radius-md);\n background: var(--neutral-50);\n border: 1px solid var(--neutral-200);\n font-size: 14.5px;\n }\n\n .objects-list li .obj-label {\n color: var(--neutral-700);\n }\n\n .objects-list li .obj-amt {\n font-weight: 700;\n color: var(--neutral-900);\n white-space: nowrap;\n margin-left: 16px;\n background: var(--surface);\n padding: 2px 8px;\n border-radius: var(--radius-sm);\n border: 1px solid var(--neutral-200);\n }\n\n \/* ==========================================================================\n 9. VERDICT BOX & CTA\n ========================================================================== *\/\n .cmr-verdict-card {\n background: linear-gradient(145deg, #ffffff 0%, var(--brand-light) 100%);\n border: 1px solid var(--brand-border);\n border-left: 5px solid var(--brand-primary);\n padding: 24px;\n border-radius: var(--radius-md);\n margin: 36px 0;\n }\n\n .cmr-verdict-title {\n font-size: 17px;\n font-weight: 800;\n color: var(--neutral-900);\n margin-bottom: 8px;\n }\n\n .cta-wrap {\n text-align: center;\n margin: 36px 0 16px;\n }\n\n .cta-btn {\n display: inline-flex;\n align-items: center;\n justify-content: center;\n gap: 8px;\n background: var(--brand-primary);\n color: #ffffff !important;\n font-size: 15px;\n font-weight: 700;\n text-decoration: none !important;\n padding: 14px 36px;\n border-radius: var(--radius-full);\n box-shadow: 0 4px 14px rgba(22, 163, 74, 0.25);\n transition: all 0.2s ease;\n cursor: pointer;\n }\n\n .cta-btn:hover {\n background: var(--brand-primary-hover);\n transform: translateY(-2px);\n box-shadow: 0 6px 20px rgba(22, 163, 74, 0.35);\n }\n\n .source-note {\n font-size: 12px;\n color: var(--neutral-500);\n margin-top: 32px;\n border-top: 1px solid var(--neutral-200);\n padding-top: 14px;\n text-align: center;\n }\n\n hr.divider {\n border: none;\n border-top: 1px solid var(--neutral-200);\n margin: 32px 0;\n }\n\n \/* ==========================================================================\n 10. RESPONSIVE MOBILE BREAKPOINTS\n ========================================================================== *\/\n @media (max-width: 640px) {\n .cmr-article-wrapper {\n margin: 16px 12px;\n padding: 24px 16px;\n border-radius: var(--radius-md);\n }\n\n h1.post-title {\n font-size: 22px;\n }\n\n .cmr-glance-grid {\n grid-template-columns: repeat(2, 1fr);\n }\n\n .kpi-grid {\n grid-template-columns: repeat(2, 1fr);\n }\n\n .objects-list li {\n flex-direction: column;\n align-items: flex-start;\n gap: 6px;\n }\n\n .objects-list li .obj-amt {\n margin-left: 0;\n }\n\n .cta-btn {\n width: 100%;\n padding: 14px 20px;\n }\n }\n <\/style>\n<\/head>\n<body>\n\n<main class=\"cmr-article-wrapper\">\n\n\n \n <div class=\"cmr-glance-title\">IPO Summary<\/div>\n \n <div class=\"cmr-glance-grid\">\n <div class=\"cmr-glance-item cmr-highlight\">\n <div class=\"cmr-g-label\">Price Band<\/div>\n <div class=\"cmr-g-value\">\u20b9938 \u2013 \u20b9988<\/div>\n <div class=\"cmr-g-sub\">FV: \u20b92 \/ share<\/div>\n <\/div>\n\n <div class=\"cmr-glance-item cmr-highlight\">\n <div class=\"cmr-g-label\">Issue Dates<\/div>\n <div class=\"cmr-g-value\">Aug 24 \u2013 27<\/div>\n <div class=\"cmr-g-sub\">Year: 2026<\/div>\n <\/div>\n\n <div class=\"cmr-glance-item\">\n <div class=\"cmr-g-label\">Lot Size<\/div>\n <div class=\"cmr-g-value\">15 Shares<\/div>\n <div class=\"cmr-g-sub\">Min: \u20b914,820<\/div>\n <\/div>\n\n <div class=\"cmr-glance-item\">\n <div class=\"cmr-g-label\">Total Issue Size<\/div>\n <div class=\"cmr-g-value\">\u20b91,757 Cr<\/div>\n <div class=\"cmr-g-sub\">Fresh + OFS<\/div>\n <\/div>\n\n <div class=\"cmr-glance-item\">\n <div class=\"cmr-g-label\">Listing At<\/div>\n <div class=\"cmr-g-value\">BSE & NSE<\/div>\n <div class=\"cmr-g-sub\">Tentative: Sep 1<\/div>\n <\/div>\n\n <div class=\"cmr-glance-item\">\n <div class=\"cmr-g-label\">Lead Manager<\/div>\n <div class=\"cmr-g-value\" style=\"font-size: 14px;\">JM Financial<\/div>\n <div class=\"cmr-g-sub\">Reg: MUFG Intime<\/div>\n <\/div>\n <\/div>\n\n \n\n \n <h2 class=\"section-heading\">About the Business<\/h2>\n <p>\n Incorporated in <strong>2002<\/strong>, Symbiotec Pharmalab Limited is a leading pharmaceutical and biotechnology company focused on the development and manufacturing of Active Pharmaceutical Ingredients (APIs), specialty products, and nutritional ingredients. With over 30 years of operational experience starting from a lab-scale steroidal hormone API manufacturer in 1995, the company has transformed into a globally recognized, industrial-scale, backward-integrated platform.\n <\/p>\n <p>\n Symbiotec operates two large-scale manufacturing facilities with chemical synthesis capacity of 584.67 metric tonnes (MT) and fermentation capacity of 300 kilolitres. Its units are certified by premier global regulatory authorities, including the United States FDA, European Union Good Manufacturing Practices (EU-GMP), and the Ministry of Food and Drug Safety, Korea.\n <\/p>\n\n <ul class=\"cmr-feature-list\">\n <li>Global leadership in corticosteroid and steroidal hormone Active Pharmaceutical Ingredients (APIs).<\/li>\n <li>Vertically integrated manufacturing facilities with US FDA, EU-GMP, and international regulatory approvals.<\/li>\n <li>Long-standing relationships with tier-1 global pharmaceutical and wellness clients.<\/li>\n <li>Continuous R&D investments driving high-value, intellectual property-led product pipelines.<\/li>\n <\/ul>\n\n <p>\n The company’s promoters are <strong>Anil Satwani, Kashish Satwani, Sushil Satwani, and Satwani Holdings LLP<\/strong>.\n <\/p>\n\n <hr class=\"divider\" \/>\n\n \n <h2 class=\"section-heading\">Financial Overview<\/h2>\n <p>\n Symbiotec Pharmalab Ltd. demonstrated steady financial performance, with total income growing by 15% and Profit After Tax (PAT) increasing by 14% between FY25 and FY26.\n <\/p>\n\n <div class=\"table-container\">\n <table class=\"fin-table\">\n <thead>\n <tr>\n <th>Metric (\u20b9 Cr)<\/th>\n <th>FY 2026<\/th>\n <th>FY 2025<\/th>\n <th>FY 2024<\/th>\n <\/tr>\n <\/thead>\n <tbody>\n <tr><td>Total Income<\/td><td>\u20b9872.26<\/td><td>\u20b9755.98<\/td><td>\u20b9723.33<\/td><\/tr>\n <tr><td>EBITDA<\/td><td>\u20b9231.97<\/td><td>\u20b9206.11<\/td><td>\u20b9177.04<\/td><\/tr>\n <tr><td>PAT (Profit After Tax)<\/td><td>\u20b9109.90<\/td><td>\u20b996.79<\/td><td>\u20b9100.06<\/td><\/tr>\n <tr><td>Net Worth<\/td><td>\u20b91,158.64<\/td><td>\u20b9821.15<\/td><td>\u20b9720.68<\/td><\/tr>\n <tr><td>Reserves & Surplus<\/td><td>\u20b91,145.95<\/td><td>\u20b9810.03<\/td><td>\u20b9709.54<\/td><\/tr>\n <tr><td>Total Borrowings<\/td><td>\u20b9387.91<\/td><td>\u20b9540.92<\/td><td>\u20b9247.21<\/td><\/tr>\n <tr><td>Total Assets<\/td><td>\u20b91,780.79<\/td><td>\u20b91,579.65<\/td><td>\u20b91,294.79<\/td><\/tr>\n <\/tbody>\n <\/table>\n <\/div>\n <p class=\"fin-note\">Restated Consolidated Figures | Source: RHP Filings<\/p>\n\n \n <h2 class=\"section-heading\">Key Financial Metrics (FY26)<\/h2>\n <div class=\"kpi-grid\">\n <div class=\"kpi-card\">\n <div class=\"kpi-value\">26.59%<\/div>\n <div class=\"kpi-label\">EBITDA Margin<\/div>\n <\/div>\n <div class=\"kpi-card\">\n <div class=\"kpi-value\">12.60%<\/div>\n <div class=\"kpi-label\">PAT Margin<\/div>\n <\/div>\n <div class=\"kpi-card\">\n <div class=\"kpi-value\">11.56%<\/div>\n <div class=\"kpi-label\">ROCE<\/div>\n <\/div>\n <div class=\"kpi-card\">\n <div class=\"kpi-value\">\u20b9184.69<\/div>\n <div class=\"kpi-label\">NAV per share<\/div>\n <\/div>\n <div class=\"kpi-card\">\n <div class=\"kpi-value\">\u20b917.39<\/div>\n <div class=\"kpi-label\">Post-IPO EPS<\/div>\n <\/div>\n <div class=\"kpi-card\">\n <div class=\"kpi-value\">56.81x<\/div>\n <div class=\"kpi-label\">Post-IPO P\/E<\/div>\n <\/div>\n <\/div>\n\n <hr class=\"divider\" \/>\n\n \n <h2 class=\"section-heading\">Issue Reservation<\/h2>\n <div class=\"table-container\">\n <table class=\"res-table\">\n <thead>\n <tr>\n <th>Investor Category<\/th>\n <th>Allocation Limit<\/th>\n <\/tr>\n <\/thead>\n <tbody>\n <tr><td>QIB Shares Offered<\/td><td>Not more than 50% of the Net Offer<\/td><\/tr>\n <tr><td>Retail (RII) Shares Offered<\/td><td>Not less than 35% of the Net Offer<\/td><\/tr>\n <tr><td>NII (HNI) Shares Offered<\/td><td>Not less than 15% of the Net Offer<\/td><\/tr>\n <\/tbody>\n <\/table>\n <\/div>\n <p class=\"fin-note\">Employee Discount: \u20b990.00 per share is applicable for eligible employees.<\/p>\n\n <hr class=\"divider\" \/>\n\n \n <h2 class=\"section-heading\">Objects of the Issue<\/h2>\n <p>\n The net proceeds from the \u20b9150.00 Cr fresh issue are proposed to be utilized towards:\n <\/p>\n <ul class=\"objects-list\">\n <li>\n <span class=\"obj-label\">Prepayment or scheduled repayment of certain outstanding borrowings<\/span>\n <span class=\"obj-amt\">\u20b9112.50 Cr<\/span>\n <\/li>\n <li>\n <span class=\"obj-label\">General corporate purposes<\/span>\n <span class=\"obj-amt\">Balance<\/span>\n <\/li>\n <\/ul>\n\n \n <div class=\"cmr-verdict-card\">\n <div class=\"cmr-verdict-title\">The Final Verdict<\/div>\n <p>\n Symbiotec Pharmalab Limited brings strong technical capabilities and international regulatory credentials in specialized steroid and hormone APIs, generating high EBITDA margins of 26.59% and a PAT of \u20b9109.90 Cr in FY26.\n <\/p>\n <p style=\"margin-top: 10px;\">\n Using \u20b9112.50 Cr of fresh issue proceeds for debt prepayment will strengthen its balance sheet and reduce finance costs. At an upper price band of \u20b9988, the issue is valued at a post-issue P\/E of 56.81x with a market cap of \u20b96,244.43 Cr. Investors looking for niche, export-oriented active pharmaceutical ingredient players can evaluate this issue for medium-to-long term portfolios.\n <\/p>\n <\/div>\n\n \n <div class=\"cta-wrap\">\n <a class=\"cta-btn\" href=\"https:\/\/novo.flattrade.in\/\" target=\"_blank\" rel=\"noopener\">\n Apply for Symbiotec Pharmalab IPO on Flattrade →\n <\/a>\n <\/div>\n\n <div class=\"source-note\">Source: Chittorgarh IPO Filings<\/div>\n\n<\/main>\n\n<\/body>\n<\/html>\n\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-a986d79 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"a986d79\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-5debab7\" data-id=\"5debab7\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-e7c963c elementor-widget elementor-widget-text-editor\" data-id=\"e7c963c\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/google.com\/preferences\/source?q=https:\/\/flattrade.in\/\" class=\"ft-google-mini-btn\">\n\n\n <div class=\"mini-btn-content\">\n\n <span class=\"mini-top\">\n Stay updated with\n <\/span>\n\n <span class=\"mini-main\">\n\n <span class=\"flattrade-logo\">\n FLAT<span>TRADE<\/span>\n <small>KOSH<\/small>\n <\/span>\n \n\n on\n\n <span class=\"google-text\">\n <span class=\"g-blue\">G<\/span><span class=\"g-red\">o<\/span><span class=\"g-yellow\">o<\/span><span class=\"g-blue\">g<\/span><span class=\"g-green\">l<\/span><span class=\"g-red\">e<\/span>\n <\/span>\n\n <span class=\"arrow\">\u2197<\/span>\n\n <\/span>\n\n <span class=\"mini-desc\">\n Get market insights, IPO updates, and finance explainers more easily.\n <\/span>\n\n <\/div>\n\n<\/a>\n\n<style>\n\n\/* =========================\n FONT\n========================= *\/\n\n\n\/* =========================\n GLOBAL\n========================= *\/\n\n*{\n box-sizing:border-box;\n}\n\n\/* =========================\n BUTTON\n========================= *\/\n\n.ft-google-mini-btn{\n\n position:relative;\n\n display:inline-flex;\n\n align-items:center;\n\n gap:14px;\n\n width:100%;\n max-width:420px;\n\n padding:14px 16px;\n\n border-radius:18px;\n\n text-decoration:none;\n\n overflow:hidden;\n\n font-family:'Plus Jakarta Sans',sans-serif;\n\n border:1px solid #e5ebf5;\n\n background:\n linear-gradient(\n 135deg,\n #ffffff 0%,\n #f8fbff 50%,\n #f4f8fd 100%\n );\n\n box-shadow:\n 0 3px 8px rgba(15,23,42,0.03),\n 0 10px 20px rgba(15,23,42,0.05);\n\n transition:\n transform 0.25s ease,\n box-shadow 0.25s ease;\n}\n\n\/* =========================\n HOVER\n========================= *\/\n\n.ft-google-mini-btn:hover{\n\n transform:translateY(-2px);\n\n box-shadow:\n 0 8px 18px rgba(15,23,42,0.06),\n 0 18px 30px rgba(37,99,235,0.07);\n}\n\n\/* =========================\n GOOGLE ICON\n========================= *\/\n\n.google-icon{\n\n width:42px;\n\n height:42px;\n\n min-width:42px;\n}\n\n\/* =========================\n CONTENT\n========================= *\/\n\n.mini-btn-content{\n display:flex;\n flex-direction:column;\n}\n\n\/* =========================\n TOP TEXT\n========================= *\/\n\n.mini-top{\n\n font-size:11px;\n\n line-height:1.3;\n\n font-weight:700;\n\n color:#64748b;\n\n margin-bottom:2px;\n}\n\n\/* =========================\n MAIN TEXT\n========================= *\/\n\n.mini-main{\n\n font-size:15px;\n\n line-height:1.35;\n\n font-weight:800;\n\n color:#0f172a;\n}\n\n\/* =========================\n FLATTRADE LOGO\n========================= *\/\n\n.flattrade-logo{\n\n position:relative;\n\n display:inline-block;\n\n font-size:15px;\n\n font-weight:800;\n\n letter-spacing:-0.3px;\n\n color:#111827;\n}\n\n.flattrade-logo span{\n color:#2563eb;\n}\n\n.flattrade-logo small{\n\n position:absolute;\n\n right:-1px;\n\n bottom:-5px;\n\n font-size:4px;\n\n font-weight:800;\n\n color:#2563eb;\n\n letter-spacing:0.4px;\n}\n\n\/* =========================\n GOOGLE COLORS\n========================= *\/\n\n.google-text{\n font-weight:800;\n}\n\n.g-blue{\n color:#4285F4;\n}\n\n.g-red{\n color:#EA4335;\n}\n\n.g-yellow{\n color:#FBBC05;\n}\n\n.g-green{\n color:#34A853;\n}\n\n\/* =========================\n ARROW\n========================= *\/\n\n.arrow{\n color:#2563eb;\n}\n\n\/* =========================\n DESCRIPTION\n========================= *\/\n\n.mini-desc{\n\n margin-top:4px;\n\n font-size:10px;\n\n line-height:1.5;\n\n font-weight:500;\n\n color:#64748b;\n}\n\n\/* =========================\n MOBILE\n========================= *\/\n\n@media(max-width:480px){\n\n .ft-google-mini-btn{\n\n max-width:100%;\n\n padding:12px 14px;\n\n border-radius:16px;\n }\n\n .google-icon{\n\n width:36px;\n\n height:36px;\n\n min-width:36px;\n }\n\n .mini-main,\n .flattrade-logo{\n font-size:13px;\n }\n\n .mini-desc{\n font-size:9px;\n }\n\n}\n\n.ft-google-mini-btn {\n position: relative;\n display: inline-flex;\n align-items: center;\n gap: 14px;\n width: 100%;\n max-width: 420px;\n padding: 14px 16px;\n border-radius: 18px;\n text-decoration: none;\n overflow: hidden;\n font-family: 'Plus Jakarta Sans', sans-serif;\n\n \/* --- ENHANCED BORDER --- *\/\n border: 2px solid #2563eb; \/* Using the brand blue for a strong identity *\/\n \/* Alternative: border: 1.5px solid #cbd5e1; for a subtle slate grey *\/\n \n background: linear-gradient(135deg, #ffffff 0%, #f8fbff 50%, #f4f8fd 100%);\n box-shadow: 0 3px 8px rgba(15,23,42,0.03), 0 10px 20px rgba(15,23,42,0.05);\n transition: all 0.25s ease;\n}\n\n\/* =========================\n HOVER STATE BORDER\n========================= *\/\n.ft-google-mini-btn:hover {\n transform: translateY(-2px);\n border-color: #c5d4ff; \/* Darkens the border slightly on hover *\/\n box-shadow: 0 8px 12px rgba(37,99,235,0.15);\n}\n\n\n\n<\/style>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"Symbiotec Pharmalab IPO \u2013 Flattrade Kosh IPO Summary Price Band \u20b9938 \u2013 \u20b9988 FV: \u20b92 \/ share Issue…","protected":false},"author":10,"featured_media":52986,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"csco_display_header_overlay":false,"csco_singular_sidebar":"","csco_page_header_type":"","csco_page_load_nextpost":"","csco_post_video_location":[],"csco_post_video_location_hash":"","csco_post_video_url":"","csco_post_video_bg_start_time":0,"csco_post_video_bg_end_time":0,"csco_post_video_bg_volume":false,"footnotes":""},"categories":[15],"tags":[],"class_list":["post-52982","post","type-post","status-publish","format-standard","has-post-thumbnail","category-ipos","cs-entry","cs-video-wrap"],"yoast_head":"\n<title>Symbiotec Pharmalab IPO - Flattrade Kosh<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flattrade.in\/kosh\/symbiotec-pharmalab-ipo\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Symbiotec Pharmalab IPO - Flattrade Kosh\" \/>\n<meta property=\"og:description\" content=\"Symbiotec Pharmalab IPO \u2013 Flattrade Kosh IPO Summary Price Band \u20b9938 \u2013 \u20b9988 FV: \u20b92 \/ share Issue…\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flattrade.in\/kosh\/symbiotec-pharmalab-ipo\/\" \/>\n<meta property=\"og:site_name\" content=\"Flattrade Kosh\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-22T07:08:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flattrade.in\/kosh\/wp-content\/uploads\/2026\/08\/WhatsApp-Image-2026-08-19-at-1.03.03-PM.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Prashant Gorhe\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@GorhePrashant\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Prashant Gorhe\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/flattrade.in\/kosh\/symbiotec-pharmalab-ipo\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/flattrade.in\/kosh\/symbiotec-pharmalab-ipo\/\"},\"author\":{\"name\":\"Prashant Gorhe\",\"@id\":\"https:\/\/flattrade.in\/kosh\/#\/schema\/person\/4abc93838bc7642e3e445b74cd627dc2\"},\"headline\":\"Symbiotec Pharmalab IPO\",\"datePublished\":\"2026-08-22T07:08:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/flattrade.in\/kosh\/symbiotec-pharmalab-ipo\/\"},\"wordCount\":474,\"image\":{\"@id\":\"https:\/\/flattrade.in\/kosh\/symbiotec-pharmalab-ipo\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/flattrade.in\/kosh\/wp-content\/uploads\/2026\/08\/WhatsApp-Image-2026-08-19-at-1.03.03-PM.jpeg\",\"articleSection\":[\"IPOs\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/flattrade.in\/kosh\/symbiotec-pharmalab-ipo\/\",\"url\":\"https:\/\/flattrade.in\/kosh\/symbiotec-pharmalab-ipo\/\",\"name\":\"Symbiotec Pharmalab IPO - Flattrade Kosh\",\"isPartOf\":{\"@id\":\"https:\/\/flattrade.in\/kosh\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/flattrade.in\/kosh\/symbiotec-pharmalab-ipo\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/flattrade.in\/kosh\/symbiotec-pharmalab-ipo\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/flattrade.in\/kosh\/wp-content\/uploads\/2026\/08\/WhatsApp-Image-2026-08-19-at-1.03.03-PM.jpeg\",\"datePublished\":\"2026-08-22T07:08:42+00:00\",\"author\":{\"@id\":\"https:\/\/flattrade.in\/kosh\/#\/schema\/person\/4abc93838bc7642e3e445b74cd627dc2\"},\"breadcrumb\":{\"@id\":\"https:\/\/flattrade.in\/kosh\/symbiotec-pharmalab-ipo\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/flattrade.in\/kosh\/symbiotec-pharmalab-ipo\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/flattrade.in\/kosh\/symbiotec-pharmalab-ipo\/#primaryimage\",\"url\":\"https:\/\/flattrade.in\/kosh\/wp-content\/uploads\/2026\/08\/WhatsApp-Image-2026-08-19-at-1.03.03-PM.jpeg\",\"contentUrl\":\"https:\/\/flattrade.in\/kosh\/wp-content\/uploads\/2026\/08\/WhatsApp-Image-2026-08-19-at-1.03.03-PM.jpeg\",\"width\":1200,\"height\":675},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/flattrade.in\/kosh\/symbiotec-pharmalab-ipo\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/flattrade.in\/kosh\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Symbiotec Pharmalab IPO\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/flattrade.in\/kosh\/#website\",\"url\":\"https:\/\/flattrade.in\/kosh\/\",\"name\":\"Flattrade Kosh\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/flattrade.in\/kosh\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/flattrade.in\/kosh\/#\/schema\/person\/4abc93838bc7642e3e445b74cd627dc2\",\"name\":\"Prashant Gorhe\",\"sameAs\":[\"http:\/\/prashantgorhe.com\",\"https:\/\/www.instagram.com\/prashant_gorhe\/\",\"https:\/\/www.linkedin.com\/in\/prashantgorhe\/\",\"https:\/\/x.com\/GorhePrashant\"],\"url\":\"https:\/\/flattrade.in\/kosh\/author\/prashant\/\"}]}<\/script>\n","yoast_head_json":{"title":"Symbiotec Pharmalab IPO - Flattrade Kosh","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flattrade.in\/kosh\/symbiotec-pharmalab-ipo\/","og_locale":"en_US","og_type":"article","og_title":"Symbiotec Pharmalab IPO - Flattrade Kosh","og_description":"Symbiotec Pharmalab IPO \u2013 Flattrade Kosh IPO Summary Price Band \u20b9938 \u2013 \u20b9988 FV: \u20b92 \/ share Issue…","og_url":"https:\/\/flattrade.in\/kosh\/symbiotec-pharmalab-ipo\/","og_site_name":"Flattrade Kosh","article_published_time":"2026-08-22T07:08:42+00:00","og_image":[{"width":1200,"height":675,"url":"https:\/\/flattrade.in\/kosh\/wp-content\/uploads\/2026\/08\/WhatsApp-Image-2026-08-19-at-1.03.03-PM.jpeg","type":"image\/jpeg"}],"author":"Prashant Gorhe","twitter_card":"summary_large_image","twitter_creator":"@GorhePrashant","twitter_misc":{"Written by":"Prashant Gorhe","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flattrade.in\/kosh\/symbiotec-pharmalab-ipo\/#article","isPartOf":{"@id":"https:\/\/flattrade.in\/kosh\/symbiotec-pharmalab-ipo\/"},"author":{"name":"Prashant Gorhe","@id":"https:\/\/flattrade.in\/kosh\/#\/schema\/person\/4abc93838bc7642e3e445b74cd627dc2"},"headline":"Symbiotec Pharmalab IPO","datePublished":"2026-08-22T07:08:42+00:00","mainEntityOfPage":{"@id":"https:\/\/flattrade.in\/kosh\/symbiotec-pharmalab-ipo\/"},"wordCount":474,"image":{"@id":"https:\/\/flattrade.in\/kosh\/symbiotec-pharmalab-ipo\/#primaryimage"},"thumbnailUrl":"https:\/\/flattrade.in\/kosh\/wp-content\/uploads\/2026\/08\/WhatsApp-Image-2026-08-19-at-1.03.03-PM.jpeg","articleSection":["IPOs"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/flattrade.in\/kosh\/symbiotec-pharmalab-ipo\/","url":"https:\/\/flattrade.in\/kosh\/symbiotec-pharmalab-ipo\/","name":"Symbiotec Pharmalab IPO - Flattrade Kosh","isPartOf":{"@id":"https:\/\/flattrade.in\/kosh\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flattrade.in\/kosh\/symbiotec-pharmalab-ipo\/#primaryimage"},"image":{"@id":"https:\/\/flattrade.in\/kosh\/symbiotec-pharmalab-ipo\/#primaryimage"},"thumbnailUrl":"https:\/\/flattrade.in\/kosh\/wp-content\/uploads\/2026\/08\/WhatsApp-Image-2026-08-19-at-1.03.03-PM.jpeg","datePublished":"2026-08-22T07:08:42+00:00","author":{"@id":"https:\/\/flattrade.in\/kosh\/#\/schema\/person\/4abc93838bc7642e3e445b74cd627dc2"},"breadcrumb":{"@id":"https:\/\/flattrade.in\/kosh\/symbiotec-pharmalab-ipo\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flattrade.in\/kosh\/symbiotec-pharmalab-ipo\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flattrade.in\/kosh\/symbiotec-pharmalab-ipo\/#primaryimage","url":"https:\/\/flattrade.in\/kosh\/wp-content\/uploads\/2026\/08\/WhatsApp-Image-2026-08-19-at-1.03.03-PM.jpeg","contentUrl":"https:\/\/flattrade.in\/kosh\/wp-content\/uploads\/2026\/08\/WhatsApp-Image-2026-08-19-at-1.03.03-PM.jpeg","width":1200,"height":675},{"@type":"BreadcrumbList","@id":"https:\/\/flattrade.in\/kosh\/symbiotec-pharmalab-ipo\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flattrade.in\/kosh\/"},{"@type":"ListItem","position":2,"name":"Symbiotec Pharmalab IPO"}]},{"@type":"WebSite","@id":"https:\/\/flattrade.in\/kosh\/#website","url":"https:\/\/flattrade.in\/kosh\/","name":"Flattrade Kosh","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flattrade.in\/kosh\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/flattrade.in\/kosh\/#\/schema\/person\/4abc93838bc7642e3e445b74cd627dc2","name":"Prashant Gorhe","sameAs":["http:\/\/prashantgorhe.com","https:\/\/www.instagram.com\/prashant_gorhe\/","https:\/\/www.linkedin.com\/in\/prashantgorhe\/","https:\/\/x.com\/GorhePrashant"],"url":"https:\/\/flattrade.in\/kosh\/author\/prashant\/"}]}},"_links":{"self":[{"href":"https:\/\/flattrade.in\/kosh\/wp-json\/wp\/v2\/posts\/52982","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flattrade.in\/kosh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flattrade.in\/kosh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flattrade.in\/kosh\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/flattrade.in\/kosh\/wp-json\/wp\/v2\/comments?post=52982"}],"version-history":[{"count":0,"href":"https:\/\/flattrade.in\/kosh\/wp-json\/wp\/v2\/posts\/52982\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flattrade.in\/kosh\/wp-json\/wp\/v2\/media\/52986"}],"wp:attachment":[{"href":"https:\/\/flattrade.in\/kosh\/wp-json\/wp\/v2\/media?parent=52982"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flattrade.in\/kosh\/wp-json\/wp\/v2\/categories?post=52982"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flattrade.in\/kosh\/wp-json\/wp\/v2\/tags?post=52982"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}

\n\t\t\t\t\t\t

\n\t\t\t\t\t

\n\t\t\t

\n\t\t\t\t\t\t

\n\t\t\t\t

\n\t\t\t\t\t\t\t\t\t\n\n\n \n \n Symbiotec Pharmalab IPO \u2013 Flattrade Kosh<\/title>\n <style>\n \/* ==========================================================================\n 1. DESIGN TOKENS & RESET\n ========================================================================== *\/\n :root {\n --brand-primary: #16a34a;\n --brand-primary-hover: #15803d;\n --brand-light: #f0fdf4;\n --brand-border: #bbf7d0;\n \n --neutral-900: #0f172a;\n --neutral-800: #1e293b;\n --neutral-700: #334155;\n --neutral-600: #475569;\n --neutral-500: #64748b;\n --neutral-200: #e2e8f0;\n --neutral-100: #f1f5f9;\n --neutral-50: #f8fafc;\n --surface: #ffffff;\n \n --radius-sm: 6px;\n --radius-md: 10px;\n --radius-lg: 16px;\n --radius-full: 9999px;\n \n --shadow-subtle: 0 1px 3px rgba(0, 0, 0, 0.04), 0 1px 2px rgba(0, 0, 0, 0.02);\n --shadow-card: 0 4px 12px -2px rgba(15, 23, 42, 0.06), 0 2px 6px -2px rgba(15, 23, 42, 0.04);\n --shadow-hover: 0 12px 24px -4px rgba(15, 23, 42, 0.10);\n \n --font-stack: -apple-system, BlinkMacSystemFont, \"Segoe UI\", Roboto, Inter, \"Helvetica Neue\", sans-serif;\n }\n\n *, *::before, *::after {\n box-sizing: border-box;\n margin: 0;\n padding: 0;\n }\n\n body {\n font-family: var(--font-stack);\n background-color: var(--neutral-50);\n color: var(--neutral-700);\n line-height: 1.75;\n -webkit-font-smoothing: antialiased;\n }\n\n \/* ==========================================================================\n 2. LAYOUT WRAPPER\n ========================================================================== *\/\n .cmr-article-wrapper {\n max-width: 760px;\n margin: 32px px 64px;\n background: var(--surface);\n border: 1px solid var(--neutral-200);\n border-radius: var(--radius-lg);\n padding: 40px 32px;\n box-shadow: var(--shadow-card);\n }\n\n \/* ==========================================================================\n 3. HEADER & META\n ========================================================================== *\/\n .meta-bar {\n display: flex;\n align-items: center;\n gap: 10px;\n margin-bottom: 18px;\n }\n\n .tag-badge {\n display: inline-flex;\n align-items: center;\n gap: 6px;\n background: var(--brand-light);\n color: var(--brand-primary);\n border: 1px solid var(--brand-border);\n border-radius: var(--radius-full);\n padding: 3px 12px;\n font-size: 11px;\n font-weight: 700;\n letter-spacing: 0.06em;\n text-transform: uppercase;\n }\n\n .tag-badge::before {\n content: \"\";\n width: 6px;\n height: 6px;\n background-color: var(--brand-primary);\n border-radius: 50%;\n }\n\n .meta-source {\n font-size: 13px;\n font-weight: 500;\n color: var(--neutral-500);\n }\n\n h1.post-title {\n font-size: 28px;\n font-weight: 800;\n color: var(--neutral-900);\n line-height: 1.25;\n letter-spacing: -0.02em;\n margin-bottom: 24px;\n }\n\n h2.section-heading {\n font-size: 19px;\n font-weight: 700;\n color: var(--neutral-900);\n margin: 36px 0 16px;\n letter-spacing: -0.01em;\n display: flex;\n align-items: center;\n gap: 8px;\n }\n\n .cmr-article-wrapper p {\n font-size: 15.5px;\n margin-bottom: 18px;\n color: var(--neutral-700);\n text-align: justify;\n }\n\n .cmr-article-wrapper strong {\n color: var(--neutral-900);\n font-weight: 600;\n }\n\n \/* ==========================================================================\n 4. IPO AT A GLANCE GRID\n ========================================================================== *\/\n .cmr-glance-title {\n font-size: 12px;\n font-weight: 700;\n color: var(--neutral-500);\n text-transform: uppercase;\n letter-spacing: 0.08em;\n margin: 28px 0 14px;\n display: flex;\n align-items: center;\n gap: 12px;\n }\n\n .cmr-glance-title::after {\n content: '';\n flex: 1;\n height: 1px;\n background: var(--neutral-200);\n }\n\n .cmr-glance-grid {\n display: grid;\n grid-template-columns: repeat(3, 1fr);\n gap: 12px;\n margin-bottom: 16px;\n }\n\n .cmr-glance-item {\n background: var(--neutral-50);\n border: 1px solid var(--neutral-200);\n border-radius: var(--radius-md);\n padding: 16px;\n transition: all 0.2s ease-in-out;\n }\n\n .cmr-glance-item:hover {\n background: var(--surface);\n border-color: #cbd5e1;\n transform: translateY(-2px);\n box-shadow: var(--shadow-subtle);\n }\n\n .cmr-glance-item.cmr-highlight {\n background: linear-gradient(145deg, #ffffff, var(--brand-light));\n border-color: var(--brand-border);\n }\n\n .cmr-glance-item.cmr-highlight .cmr-g-value {\n color: var(--brand-primary);\n }\n\n .cmr-g-label {\n font-size: 11px;\n color: var(--neutral-500);\n text-transform: uppercase;\n font-weight: 600;\n letter-spacing: 0.04em;\n margin-bottom: 4px;\n }\n\n .cmr-g-value {\n font-size: 17px;\n font-weight: 800;\n color: var(--neutral-900);\n line-height: 1.25;\n }\n\n .cmr-g-sub {\n font-size: 12px;\n color: var(--neutral-500);\n margin-top: 4px;\n }\n\n .glance-badge {\n background: var(--neutral-100);\n border: 1px solid var(--neutral-200);\n border-radius: var(--radius-sm);\n padding: 10px 14px;\n font-size: 13px;\n color: var(--neutral-600);\n margin-bottom: 28px;\n font-weight: 500;\n text-align: center;\n }\n\n \/* ==========================================================================\n 5. FEATURE LISTS\n ========================================================================== *\/\n .cmr-feature-list {\n list-style: none;\n padding: 0;\n margin: 20px 0;\n display: flex;\n flex-direction: column;\n gap: 12px;\n }\n\n .cmr-feature-list li {\n position: relative;\n padding-left: 28px;\n font-size: 15px;\n color: var(--neutral-700);\n }\n\n .cmr-feature-list li::before {\n content: \"\u2713\";\n position: absolute;\n left: 0;\n top: 1px;\n width: 18px;\n height: 18px;\n background: var(--brand-light);\n color: var(--brand-primary);\n border: 1px solid var(--brand-border);\n border-radius: 50%;\n display: flex;\n align-items: center;\n justify-content: center;\n font-size: 11px;\n font-weight: 800;\n }\n\n \/* ==========================================================================\n 6. TABLES (FINANCIAL & RESERVATION)\n ========================================================================== *\/\n .table-container {\n width: 100%;\n overflow-x: auto;\n -webkit-overflow-scrolling: touch;\n margin: 18px 0;\n border: 1px solid var(--neutral-200);\n border-radius: var(--radius-md);\n background: var(--surface);\n }\n\n .fin-table, .res-table {\n width: 100%;\n border-collapse: collapse;\n font-size: 14.5px;\n text-align: left;\n }\n\n .fin-table th, .fin-table td,\n .res-table th, .res-table td {\n padding: 12px 18px;\n border-bottom: 1px solid var(--neutral-200);\n }\n\n .fin-table thead tr, .res-table thead tr {\n background: var(--neutral-100);\n }\n\n .fin-table th {\n font-weight: 700;\n color: var(--neutral-800);\n text-align: right;\n }\n\n .fin-table th:first-child, .res-table th {\n text-align: left;\n }\n\n .fin-table td {\n color: var(--neutral-700);\n text-align: right;\n font-variant-numeric: tabular-nums;\n }\n\n .res-table td {\n color: var(--neutral-700);\n text-align: left;\n }\n\n .fin-table td:first-child, .res-table td:first-child {\n text-align: left;\n font-weight: 600;\n color: var(--neutral-900);\n }\n\n .fin-table tbody tr:hover, .res-table tbody tr:hover {\n background-color: var(--neutral-50);\n }\n\n .fin-table tbody tr:last-child td, .res-table tbody tr:last-child td {\n border-bottom: none;\n }\n\n .fin-note {\n font-size: 12px;\n color: var(--neutral-500);\n margin-top: 6px;\n margin-bottom: 24px;\n }\n\n \/* ==========================================================================\n 7. KPI STATS CARDS\n ========================================================================== *\/\n .kpi-grid {\n display: grid;\n grid-template-columns: repeat(3, 1fr);\n gap: 12px;\n margin: 20px 0 28px;\n }\n\n .kpi-card {\n background: var(--neutral-50);\n border: 1px solid var(--neutral-200);\n border-radius: var(--radius-md);\n padding: 16px 12px;\n text-align: center;\n transition: all 0.2s ease;\n }\n\n .kpi-card:hover {\n background: var(--surface);\n border-color: var(--brand-border);\n transform: translateY(-2px);\n box-shadow: var(--shadow-subtle);\n }\n\n .kpi-card .kpi-value {\n font-size: 20px;\n font-weight: 800;\n color: var(--brand-primary);\n line-height: 1.2;\n }\n\n .kpi-card .kpi-label {\n font-size: 11px;\n color: var(--neutral-500);\n text-transform: uppercase;\n letter-spacing: 0.05em;\n margin-top: 4px;\n font-weight: 600;\n }\n\n \/* ==========================================================================\n 8. OBJECTS OF THE ISSUE LIST\n ========================================================================== *\/\n .objects-list {\n list-style: none;\n padding: 0;\n margin: 20px 0;\n display: flex;\n flex-direction: column;\n gap: 10px;\n }\n\n .objects-list li {\n display: flex;\n justify-content: space-between;\n align-items: center;\n padding: 14px 18px;\n border-radius: var(--radius-md);\n background: var(--neutral-50);\n border: 1px solid var(--neutral-200);\n font-size: 14.5px;\n }\n\n .objects-list li .obj-label {\n color: var(--neutral-700);\n }\n\n .objects-list li .obj-amt {\n font-weight: 700;\n color: var(--neutral-900);\n white-space: nowrap;\n margin-left: 16px;\n background: var(--surface);\n padding: 2px 8px;\n border-radius: var(--radius-sm);\n border: 1px solid var(--neutral-200);\n }\n\n \/* ==========================================================================\n 9. VERDICT BOX & CTA\n ========================================================================== *\/\n .cmr-verdict-card {\n background: linear-gradient(145deg, #ffffff 0%, var(--brand-light) 100%);\n border: 1px solid var(--brand-border);\n border-left: 5px solid var(--brand-primary);\n padding: 24px;\n border-radius: var(--radius-md);\n margin: 36px 0;\n }\n\n .cmr-verdict-title {\n font-size: 17px;\n font-weight: 800;\n color: var(--neutral-900);\n margin-bottom: 8px;\n }\n\n .cta-wrap {\n text-align: center;\n margin: 36px 0 16px;\n }\n\n .cta-btn {\n display: inline-flex;\n align-items: center;\n justify-content: center;\n gap: 8px;\n background: var(--brand-primary);\n color: #ffffff !important;\n font-size: 15px;\n font-weight: 700;\n text-decoration: none !important;\n padding: 14px 36px;\n border-radius: var(--radius-full);\n box-shadow: 0 4px 14px rgba(22, 163, 74, 0.25);\n transition: all 0.2s ease;\n cursor: pointer;\n }\n\n .cta-btn:hover {\n background: var(--brand-primary-hover);\n transform: translateY(-2px);\n box-shadow: 0 6px 20px rgba(22, 163, 74, 0.35);\n }\n\n .source-note {\n font-size: 12px;\n color: var(--neutral-500);\n margin-top: 32px;\n border-top: 1px solid var(--neutral-200);\n padding-top: 14px;\n text-align: center;\n }\n\n hr.divider {\n border: none;\n border-top: 1px solid var(--neutral-200);\n margin: 32px 0;\n }\n\n \/* ==========================================================================\n 10. RESPONSIVE MOBILE BREAKPOINTS\n ========================================================================== *\/\n @media (max-width: 640px) {\n .cmr-article-wrapper {\n margin: 16px 12px;\n padding: 24px 16px;\n border-radius: var(--radius-md);\n }\n\n h1.post-title {\n font-size: 22px;\n }\n\n .cmr-glance-grid {\n grid-template-columns: repeat(2, 1fr);\n }\n\n .kpi-grid {\n grid-template-columns: repeat(2, 1fr);\n }\n\n .objects-list li {\n flex-direction: column;\n align-items: flex-start;\n gap: 6px;\n }\n\n .objects-list li .obj-amt {\n margin-left: 0;\n }\n\n .cta-btn {\n width: 100%;\n padding: 14px 20px;\n }\n }\n <\/style>\n<\/head>\n<body>\n\n<main class=\"cmr-article-wrapper\">\n\n\n \n <div class=\"cmr-glance-title\">IPO Summary<\/div>\n \n <div class=\"cmr-glance-grid\">\n <div class=\"cmr-glance-item cmr-highlight\">\n <div class=\"cmr-g-label\">Price Band<\/div>\n <div class=\"cmr-g-value\">\u20b9938 \u2013 \u20b9988<\/div>\n <div class=\"cmr-g-sub\">FV: \u20b92 \/ share<\/div>\n <\/div>\n\n <div class=\"cmr-glance-item cmr-highlight\">\n <div class=\"cmr-g-label\">Issue Dates<\/div>\n <div class=\"cmr-g-value\">Aug 24 \u2013 27<\/div>\n <div class=\"cmr-g-sub\">Year: 2026<\/div>\n <\/div>\n\n <div class=\"cmr-glance-item\">\n <div class=\"cmr-g-label\">Lot Size<\/div>\n <div class=\"cmr-g-value\">15 Shares<\/div>\n <div class=\"cmr-g-sub\">Min: \u20b914,820<\/div>\n <\/div>\n\n <div class=\"cmr-glance-item\">\n <div class=\"cmr-g-label\">Total Issue Size<\/div>\n <div class=\"cmr-g-value\">\u20b91,757 Cr<\/div>\n <div class=\"cmr-g-sub\">Fresh + OFS<\/div>\n <\/div>\n\n <div class=\"cmr-glance-item\">\n <div class=\"cmr-g-label\">Listing At<\/div>\n <div class=\"cmr-g-value\">BSE & NSE<\/div>\n <div class=\"cmr-g-sub\">Tentative: Sep 1<\/div>\n <\/div>\n\n <div class=\"cmr-glance-item\">\n <div class=\"cmr-g-label\">Lead Manager<\/div>\n <div class=\"cmr-g-value\" style=\"font-size: 14px;\">JM Financial<\/div>\n <div class=\"cmr-g-sub\">Reg: MUFG Intime<\/div>\n <\/div>\n <\/div>\n\n \n\n \n <h2 class=\"section-heading\">About the Business<\/h2>\n <p>\n Incorporated in <strong>2002<\/strong>, Symbiotec Pharmalab Limited is a leading pharmaceutical and biotechnology company focused on the development and manufacturing of Active Pharmaceutical Ingredients (APIs), specialty products, and nutritional ingredients. With over 30 years of operational experience starting from a lab-scale steroidal hormone API manufacturer in 1995, the company has transformed into a globally recognized, industrial-scale, backward-integrated platform.\n <\/p>\n <p>\n Symbiotec operates two large-scale manufacturing facilities with chemical synthesis capacity of 584.67 metric tonnes (MT) and fermentation capacity of 300 kilolitres. Its units are certified by premier global regulatory authorities, including the United States FDA, European Union Good Manufacturing Practices (EU-GMP), and the Ministry of Food and Drug Safety, Korea.\n <\/p>\n\n <ul class=\"cmr-feature-list\">\n <li>Global leadership in corticosteroid and steroidal hormone Active Pharmaceutical Ingredients (APIs).<\/li>\n <li>Vertically integrated manufacturing facilities with US FDA, EU-GMP, and international regulatory approvals.<\/li>\n <li>Long-standing relationships with tier-1 global pharmaceutical and wellness clients.<\/li>\n <li>Continuous R&D investments driving high-value, intellectual property-led product pipelines.<\/li>\n <\/ul>\n\n <p>\n The company’s promoters are <strong>Anil Satwani, Kashish Satwani, Sushil Satwani, and Satwani Holdings LLP<\/strong>.\n <\/p>\n\n <hr class=\"divider\" \/>\n\n \n <h2 class=\"section-heading\">Financial Overview<\/h2>\n <p>\n Symbiotec Pharmalab Ltd. demonstrated steady financial performance, with total income growing by 15% and Profit After Tax (PAT) increasing by 14% between FY25 and FY26.\n <\/p>\n\n <div class=\"table-container\">\n <table class=\"fin-table\">\n <thead>\n <tr>\n <th>Metric (\u20b9 Cr)<\/th>\n <th>FY 2026<\/th>\n <th>FY 2025<\/th>\n <th>FY 2024<\/th>\n <\/tr>\n <\/thead>\n <tbody>\n <tr><td>Total Income<\/td><td>\u20b9872.26<\/td><td>\u20b9755.98<\/td><td>\u20b9723.33<\/td><\/tr>\n <tr><td>EBITDA<\/td><td>\u20b9231.97<\/td><td>\u20b9206.11<\/td><td>\u20b9177.04<\/td><\/tr>\n <tr><td>PAT (Profit After Tax)<\/td><td>\u20b9109.90<\/td><td>\u20b996.79<\/td><td>\u20b9100.06<\/td><\/tr>\n <tr><td>Net Worth<\/td><td>\u20b91,158.64<\/td><td>\u20b9821.15<\/td><td>\u20b9720.68<\/td><\/tr>\n <tr><td>Reserves & Surplus<\/td><td>\u20b91,145.95<\/td><td>\u20b9810.03<\/td><td>\u20b9709.54<\/td><\/tr>\n <tr><td>Total Borrowings<\/td><td>\u20b9387.91<\/td><td>\u20b9540.92<\/td><td>\u20b9247.21<\/td><\/tr>\n <tr><td>Total Assets<\/td><td>\u20b91,780.79<\/td><td>\u20b91,579.65<\/td><td>\u20b91,294.79<\/td><\/tr>\n <\/tbody>\n <\/table>\n <\/div>\n <p class=\"fin-note\">Restated Consolidated Figures | Source: RHP Filings<\/p>\n\n \n <h2 class=\"section-heading\">Key Financial Metrics (FY26)<\/h2>\n <div class=\"kpi-grid\">\n <div class=\"kpi-card\">\n <div class=\"kpi-value\">26.59%<\/div>\n <div class=\"kpi-label\">EBITDA Margin<\/div>\n <\/div>\n <div class=\"kpi-card\">\n <div class=\"kpi-value\">12.60%<\/div>\n <div class=\"kpi-label\">PAT Margin<\/div>\n <\/div>\n <div class=\"kpi-card\">\n <div class=\"kpi-value\">11.56%<\/div>\n <div class=\"kpi-label\">ROCE<\/div>\n <\/div>\n <div class=\"kpi-card\">\n <div class=\"kpi-value\">\u20b9184.69<\/div>\n <div class=\"kpi-label\">NAV per share<\/div>\n <\/div>\n <div class=\"kpi-card\">\n <div class=\"kpi-value\">\u20b917.39<\/div>\n <div class=\"kpi-label\">Post-IPO EPS<\/div>\n <\/div>\n <div class=\"kpi-card\">\n <div class=\"kpi-value\">56.81x<\/div>\n <div class=\"kpi-label\">Post-IPO P\/E<\/div>\n <\/div>\n <\/div>\n\n <hr class=\"divider\" \/>\n\n \n <h2 class=\"section-heading\">Issue Reservation<\/h2>\n <div class=\"table-container\">\n <table class=\"res-table\">\n <thead>\n <tr>\n <th>Investor Category<\/th>\n <th>Allocation Limit<\/th>\n <\/tr>\n <\/thead>\n <tbody>\n <tr><td>QIB Shares Offered<\/td><td>Not more than 50% of the Net Offer<\/td><\/tr>\n <tr><td>Retail (RII) Shares Offered<\/td><td>Not less than 35% of the Net Offer<\/td><\/tr>\n <tr><td>NII (HNI) Shares Offered<\/td><td>Not less than 15% of the Net Offer<\/td><\/tr>\n <\/tbody>\n <\/table>\n <\/div>\n <p class=\"fin-note\">Employee Discount: \u20b990.00 per share is applicable for eligible employees.<\/p>\n\n <hr class=\"divider\" \/>\n\n \n <h2 class=\"section-heading\">Objects of the Issue<\/h2>\n <p>\n The net proceeds from the \u20b9150.00 Cr fresh issue are proposed to be utilized towards:\n <\/p>\n <ul class=\"objects-list\">\n <li>\n <span class=\"obj-label\">Prepayment or scheduled repayment of certain outstanding borrowings<\/span>\n <span class=\"obj-amt\">\u20b9112.50 Cr<\/span>\n <\/li>\n <li>\n <span class=\"obj-label\">General corporate purposes<\/span>\n <span class=\"obj-amt\">Balance<\/span>\n <\/li>\n <\/ul>\n\n \n <div class=\"cmr-verdict-card\">\n <div class=\"cmr-verdict-title\">The Final Verdict<\/div>\n <p>\n Symbiotec Pharmalab Limited brings strong technical capabilities and international regulatory credentials in specialized steroid and hormone APIs, generating high EBITDA margins of 26.59% and a PAT of \u20b9109.90 Cr in FY26.\n <\/p>\n <p style=\"margin-top: 10px;\">\n Using \u20b9112.50 Cr of fresh issue proceeds for debt prepayment will strengthen its balance sheet and reduce finance costs. At an upper price band of \u20b9988, the issue is valued at a post-issue P\/E of 56.81x with a market cap of \u20b96,244.43 Cr. Investors looking for niche, export-oriented active pharmaceutical ingredient players can evaluate this issue for medium-to-long term portfolios.\n <\/p>\n <\/div>\n\n \n <div class=\"cta-wrap\">\n <a class=\"cta-btn\" href=\"https:\/\/novo.flattrade.in\/\" target=\"_blank\" rel=\"noopener\">\n Apply for Symbiotec Pharmalab IPO on Flattrade →\n <\/a>\n <\/div>\n\n <div class=\"source-note\">Source: Chittorgarh IPO Filings<\/div>\n\n<\/main>\n\n<\/body>\n<\/html>\n\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-a986d79 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"a986d79\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-5debab7\" data-id=\"5debab7\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-e7c963c elementor-widget elementor-widget-text-editor\" data-id=\"e7c963c\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/google.com\/preferences\/source?q=https:\/\/flattrade.in\/\" class=\"ft-google-mini-btn\">\n\n\n <div class=\"mini-btn-content\">\n\n <span class=\"mini-top\">\n Stay updated with\n <\/span>\n\n <span class=\"mini-main\">\n\n <span class=\"flattrade-logo\">\n FLAT<span>TRADE<\/span>\n <small>KOSH<\/small>\n <\/span>\n \n\n on\n\n <span class=\"google-text\">\n <span class=\"g-blue\">G<\/span><span class=\"g-red\">o<\/span><span class=\"g-yellow\">o<\/span><span class=\"g-blue\">g<\/span><span class=\"g-green\">l<\/span><span class=\"g-red\">e<\/span>\n <\/span>\n\n <span class=\"arrow\">\u2197<\/span>\n\n <\/span>\n\n <span class=\"mini-desc\">\n Get market insights, IPO updates, and finance explainers more easily.\n <\/span>\n\n <\/div>\n\n<\/a>\n\n<style>\n\n\/* =========================\n FONT\n========================= *\/\n\n\n\/* =========================\n GLOBAL\n========================= *\/\n\n*{\n box-sizing:border-box;\n}\n\n\/* =========================\n BUTTON\n========================= *\/\n\n.ft-google-mini-btn{\n\n position:relative;\n\n display:inline-flex;\n\n align-items:center;\n\n gap:14px;\n\n width:100%;\n max-width:420px;\n\n padding:14px 16px;\n\n border-radius:18px;\n\n text-decoration:none;\n\n overflow:hidden;\n\n font-family:'Plus Jakarta Sans',sans-serif;\n\n border:1px solid #e5ebf5;\n\n background:\n linear-gradient(\n 135deg,\n #ffffff 0%,\n #f8fbff 50%,\n #f4f8fd 100%\n );\n\n box-shadow:\n 0 3px 8px rgba(15,23,42,0.03),\n 0 10px 20px rgba(15,23,42,0.05);\n\n transition:\n transform 0.25s ease,\n box-shadow 0.25s ease;\n}\n\n\/* =========================\n HOVER\n========================= *\/\n\n.ft-google-mini-btn:hover{\n\n transform:translateY(-2px);\n\n box-shadow:\n 0 8px 18px rgba(15,23,42,0.06),\n 0 18px 30px rgba(37,99,235,0.07);\n}\n\n\/* =========================\n GOOGLE ICON\n========================= *\/\n\n.google-icon{\n\n width:42px;\n\n height:42px;\n\n min-width:42px;\n}\n\n\/* =========================\n CONTENT\n========================= *\/\n\n.mini-btn-content{\n display:flex;\n flex-direction:column;\n}\n\n\/* =========================\n TOP TEXT\n========================= *\/\n\n.mini-top{\n\n font-size:11px;\n\n line-height:1.3;\n\n font-weight:700;\n\n color:#64748b;\n\n margin-bottom:2px;\n}\n\n\/* =========================\n MAIN TEXT\n========================= *\/\n\n.mini-main{\n\n font-size:15px;\n\n line-height:1.35;\n\n font-weight:800;\n\n color:#0f172a;\n}\n\n\/* =========================\n FLATTRADE LOGO\n========================= *\/\n\n.flattrade-logo{\n\n position:relative;\n\n display:inline-block;\n\n font-size:15px;\n\n font-weight:800;\n\n letter-spacing:-0.3px;\n\n color:#111827;\n}\n\n.flattrade-logo span{\n color:#2563eb;\n}\n\n.flattrade-logo small{\n\n position:absolute;\n\n right:-1px;\n\n bottom:-5px;\n\n font-size:4px;\n\n font-weight:800;\n\n color:#2563eb;\n\n letter-spacing:0.4px;\n}\n\n\/* =========================\n GOOGLE COLORS\n========================= *\/\n\n.google-text{\n font-weight:800;\n}\n\n.g-blue{\n color:#4285F4;\n}\n\n.g-red{\n color:#EA4335;\n}\n\n.g-yellow{\n color:#FBBC05;\n}\n\n.g-green{\n color:#34A853;\n}\n\n\/* =========================\n ARROW\n========================= *\/\n\n.arrow{\n color:#2563eb;\n}\n\n\/* =========================\n DESCRIPTION\n========================= *\/\n\n.mini-desc{\n\n margin-top:4px;\n\n font-size:10px;\n\n line-height:1.5;\n\n font-weight:500;\n\n color:#64748b;\n}\n\n\/* =========================\n MOBILE\n========================= *\/\n\n@media(max-width:480px){\n\n .ft-google-mini-btn{\n\n max-width:100%;\n\n padding:12px 14px;\n\n border-radius:16px;\n }\n\n .google-icon{\n\n width:36px;\n\n height:36px;\n\n min-width:36px;\n }\n\n .mini-main,\n .flattrade-logo{\n font-size:13px;\n }\n\n .mini-desc{\n font-size:9px;\n }\n\n}\n\n.ft-google-mini-btn {\n position: relative;\n display: inline-flex;\n align-items: center;\n gap: 14px;\n width: 100%;\n max-width: 420px;\n padding: 14px 16px;\n border-radius: 18px;\n text-decoration: none;\n overflow: hidden;\n font-family: 'Plus Jakarta Sans', sans-serif;\n\n \/* --- ENHANCED BORDER --- *\/\n border: 2px solid #2563eb; \/* Using the brand blue for a strong identity *\/\n \/* Alternative: border: 1.5px solid #cbd5e1; for a subtle slate grey *\/\n \n background: linear-gradient(135deg, #ffffff 0%, #f8fbff 50%, #f4f8fd 100%);\n box-shadow: 0 3px 8px rgba(15,23,42,0.03), 0 10px 20px rgba(15,23,42,0.05);\n transition: all 0.25s ease;\n}\n\n\/* =========================\n HOVER STATE BORDER\n========================= *\/\n.ft-google-mini-btn:hover {\n transform: translateY(-2px);\n border-color: #c5d4ff; \/* Darkens the border slightly on hover *\/\n box-shadow: 0 8px 12px rgba(37,99,235,0.15);\n}\n\n\n\n<\/style>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"Symbiotec Pharmalab IPO \u2013 Flattrade Kosh IPO Summary Price Band \u20b9938 \u2013 \u20b9988 FV: \u20b92 \/ share Issue…","protected":false},"author":10,"featured_media":52986,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"csco_display_header_overlay":false,"csco_singular_sidebar":"","csco_page_header_type":"","csco_page_load_nextpost":"","csco_post_video_location":[],"csco_post_video_location_hash":"","csco_post_video_url":"","csco_post_video_bg_start_time":0,"csco_post_video_bg_end_time":0,"csco_post_video_bg_volume":false,"footnotes":""},"categories":[15],"tags":[],"class_list":["post-52982","post","type-post","status-publish","format-standard","has-post-thumbnail","category-ipos","cs-entry","cs-video-wrap"],"yoast_head":"\n<title>Symbiotec Pharmalab IPO - Flattrade Kosh<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flattrade.in\/kosh\/symbiotec-pharmalab-ipo\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Symbiotec Pharmalab IPO - Flattrade Kosh\" \/>\n<meta property=\"og:description\" content=\"Symbiotec Pharmalab IPO \u2013 Flattrade Kosh IPO Summary Price Band \u20b9938 \u2013 \u20b9988 FV: \u20b92 \/ share Issue…\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flattrade.in\/kosh\/symbiotec-pharmalab-ipo\/\" \/>\n<meta property=\"og:site_name\" content=\"Flattrade Kosh\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-22T07:08:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flattrade.in\/kosh\/wp-content\/uploads\/2026\/08\/WhatsApp-Image-2026-08-19-at-1.03.03-PM.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Prashant Gorhe\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@GorhePrashant\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Prashant Gorhe\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/flattrade.in\/kosh\/symbiotec-pharmalab-ipo\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/flattrade.in\/kosh\/symbiotec-pharmalab-ipo\/\"},\"author\":{\"name\":\"Prashant Gorhe\",\"@id\":\"https:\/\/flattrade.in\/kosh\/#\/schema\/person\/4abc93838bc7642e3e445b74cd627dc2\"},\"headline\":\"Symbiotec Pharmalab IPO\",\"datePublished\":\"2026-08-22T07:08:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/flattrade.in\/kosh\/symbiotec-pharmalab-ipo\/\"},\"wordCount\":474,\"image\":{\"@id\":\"https:\/\/flattrade.in\/kosh\/symbiotec-pharmalab-ipo\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/flattrade.in\/kosh\/wp-content\/uploads\/2026\/08\/WhatsApp-Image-2026-08-19-at-1.03.03-PM.jpeg\",\"articleSection\":[\"IPOs\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/flattrade.in\/kosh\/symbiotec-pharmalab-ipo\/\",\"url\":\"https:\/\/flattrade.in\/kosh\/symbiotec-pharmalab-ipo\/\",\"name\":\"Symbiotec Pharmalab IPO - Flattrade Kosh\",\"isPartOf\":{\"@id\":\"https:\/\/flattrade.in\/kosh\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/flattrade.in\/kosh\/symbiotec-pharmalab-ipo\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/flattrade.in\/kosh\/symbiotec-pharmalab-ipo\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/flattrade.in\/kosh\/wp-content\/uploads\/2026\/08\/WhatsApp-Image-2026-08-19-at-1.03.03-PM.jpeg\",\"datePublished\":\"2026-08-22T07:08:42+00:00\",\"author\":{\"@id\":\"https:\/\/flattrade.in\/kosh\/#\/schema\/person\/4abc93838bc7642e3e445b74cd627dc2\"},\"breadcrumb\":{\"@id\":\"https:\/\/flattrade.in\/kosh\/symbiotec-pharmalab-ipo\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/flattrade.in\/kosh\/symbiotec-pharmalab-ipo\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/flattrade.in\/kosh\/symbiotec-pharmalab-ipo\/#primaryimage\",\"url\":\"https:\/\/flattrade.in\/kosh\/wp-content\/uploads\/2026\/08\/WhatsApp-Image-2026-08-19-at-1.03.03-PM.jpeg\",\"contentUrl\":\"https:\/\/flattrade.in\/kosh\/wp-content\/uploads\/2026\/08\/WhatsApp-Image-2026-08-19-at-1.03.03-PM.jpeg\",\"width\":1200,\"height\":675},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/flattrade.in\/kosh\/symbiotec-pharmalab-ipo\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/flattrade.in\/kosh\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Symbiotec Pharmalab IPO\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/flattrade.in\/kosh\/#website\",\"url\":\"https:\/\/flattrade.in\/kosh\/\",\"name\":\"Flattrade Kosh\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/flattrade.in\/kosh\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/flattrade.in\/kosh\/#\/schema\/person\/4abc93838bc7642e3e445b74cd627dc2\",\"name\":\"Prashant Gorhe\",\"sameAs\":[\"http:\/\/prashantgorhe.com\",\"https:\/\/www.instagram.com\/prashant_gorhe\/\",\"https:\/\/www.linkedin.com\/in\/prashantgorhe\/\",\"https:\/\/x.com\/GorhePrashant\"],\"url\":\"https:\/\/flattrade.in\/kosh\/author\/prashant\/\"}]}<\/script>\n","yoast_head_json":{"title":"Symbiotec Pharmalab IPO - Flattrade Kosh","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flattrade.in\/kosh\/symbiotec-pharmalab-ipo\/","og_locale":"en_US","og_type":"article","og_title":"Symbiotec Pharmalab IPO - Flattrade Kosh","og_description":"Symbiotec Pharmalab IPO \u2013 Flattrade Kosh IPO Summary Price Band \u20b9938 \u2013 \u20b9988 FV: \u20b92 \/ share Issue…","og_url":"https:\/\/flattrade.in\/kosh\/symbiotec-pharmalab-ipo\/","og_site_name":"Flattrade Kosh","article_published_time":"2026-08-22T07:08:42+00:00","og_image":[{"width":1200,"height":675,"url":"https:\/\/flattrade.in\/kosh\/wp-content\/uploads\/2026\/08\/WhatsApp-Image-2026-08-19-at-1.03.03-PM.jpeg","type":"image\/jpeg"}],"author":"Prashant Gorhe","twitter_card":"summary_large_image","twitter_creator":"@GorhePrashant","twitter_misc":{"Written by":"Prashant Gorhe","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flattrade.in\/kosh\/symbiotec-pharmalab-ipo\/#article","isPartOf":{"@id":"https:\/\/flattrade.in\/kosh\/symbiotec-pharmalab-ipo\/"},"author":{"name":"Prashant Gorhe","@id":"https:\/\/flattrade.in\/kosh\/#\/schema\/person\/4abc93838bc7642e3e445b74cd627dc2"},"headline":"Symbiotec Pharmalab IPO","datePublished":"2026-08-22T07:08:42+00:00","mainEntityOfPage":{"@id":"https:\/\/flattrade.in\/kosh\/symbiotec-pharmalab-ipo\/"},"wordCount":474,"image":{"@id":"https:\/\/flattrade.in\/kosh\/symbiotec-pharmalab-ipo\/#primaryimage"},"thumbnailUrl":"https:\/\/flattrade.in\/kosh\/wp-content\/uploads\/2026\/08\/WhatsApp-Image-2026-08-19-at-1.03.03-PM.jpeg","articleSection":["IPOs"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/flattrade.in\/kosh\/symbiotec-pharmalab-ipo\/","url":"https:\/\/flattrade.in\/kosh\/symbiotec-pharmalab-ipo\/","name":"Symbiotec Pharmalab IPO - Flattrade Kosh","isPartOf":{"@id":"https:\/\/flattrade.in\/kosh\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flattrade.in\/kosh\/symbiotec-pharmalab-ipo\/#primaryimage"},"image":{"@id":"https:\/\/flattrade.in\/kosh\/symbiotec-pharmalab-ipo\/#primaryimage"},"thumbnailUrl":"https:\/\/flattrade.in\/kosh\/wp-content\/uploads\/2026\/08\/WhatsApp-Image-2026-08-19-at-1.03.03-PM.jpeg","datePublished":"2026-08-22T07:08:42+00:00","author":{"@id":"https:\/\/flattrade.in\/kosh\/#\/schema\/person\/4abc93838bc7642e3e445b74cd627dc2"},"breadcrumb":{"@id":"https:\/\/flattrade.in\/kosh\/symbiotec-pharmalab-ipo\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flattrade.in\/kosh\/symbiotec-pharmalab-ipo\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flattrade.in\/kosh\/symbiotec-pharmalab-ipo\/#primaryimage","url":"https:\/\/flattrade.in\/kosh\/wp-content\/uploads\/2026\/08\/WhatsApp-Image-2026-08-19-at-1.03.03-PM.jpeg","contentUrl":"https:\/\/flattrade.in\/kosh\/wp-content\/uploads\/2026\/08\/WhatsApp-Image-2026-08-19-at-1.03.03-PM.jpeg","width":1200,"height":675},{"@type":"BreadcrumbList","@id":"https:\/\/flattrade.in\/kosh\/symbiotec-pharmalab-ipo\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flattrade.in\/kosh\/"},{"@type":"ListItem","position":2,"name":"Symbiotec Pharmalab IPO"}]},{"@type":"WebSite","@id":"https:\/\/flattrade.in\/kosh\/#website","url":"https:\/\/flattrade.in\/kosh\/","name":"Flattrade Kosh","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flattrade.in\/kosh\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/flattrade.in\/kosh\/#\/schema\/person\/4abc93838bc7642e3e445b74cd627dc2","name":"Prashant Gorhe","sameAs":["http:\/\/prashantgorhe.com","https:\/\/www.instagram.com\/prashant_gorhe\/","https:\/\/www.linkedin.com\/in\/prashantgorhe\/","https:\/\/x.com\/GorhePrashant"],"url":"https:\/\/flattrade.in\/kosh\/author\/prashant\/"}]}},"_links":{"self":[{"href":"https:\/\/flattrade.in\/kosh\/wp-json\/wp\/v2\/posts\/52982","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flattrade.in\/kosh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flattrade.in\/kosh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flattrade.in\/kosh\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/flattrade.in\/kosh\/wp-json\/wp\/v2\/comments?post=52982"}],"version-history":[{"count":0,"href":"https:\/\/flattrade.in\/kosh\/wp-json\/wp\/v2\/posts\/52982\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flattrade.in\/kosh\/wp-json\/wp\/v2\/media\/52986"}],"wp:attachment":[{"href":"https:\/\/flattrade.in\/kosh\/wp-json\/wp\/v2\/media?parent=52982"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flattrade.in\/kosh\/wp-json\/wp\/v2\/categories?post=52982"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flattrade.in\/kosh\/wp-json\/wp\/v2\/tags?post=52982"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}